naltrexone and Neonatal Abstinence Syndrome

naltrexone has been researched along with Neonatal Abstinence Syndrome in 8 studies

Research

Studies (8)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	2 (25.00)	18.2507
2000's	1 (12.50)	29.6817
2010's	4 (50.00)	24.3611
2020's	1 (12.50)	2.80

Authors

Authors	Studies
Hulse, G; Kelty, E	1
Griffin, BL; Stone, RH; Todd, TJ; Tran, TH; Vest, KM	1
Katz, E; Towers, CV; Visconti, K; Weitz, B	1
Chisolm, MS; Jansson, LM; Jones, HE; Terplan, M	1
Stitzer, ML	1
Barr, GA; Jones, KL	1
Barr, GA; Hamowy, AS; Hutchings, DE; Liu, PY; Wang, S; Zmitrovich, A	1
Barr, GA; Zhu, H	1

Reviews

2 review(s) available for naltrexone and Neonatal Abstinence Syndrome

Article	Year
Methadone, Buprenorphine, and Naltrexone for the Treatment of Opioid Use Disorder in Pregnant Women. Pharmacotherapy, 2017, Volume: 37, Issue:7 Topics: Analgesics, Opioid; Animals; Buprenorphine; Female; Humans; Infant, Newborn; Methadone; Naltrexone; Neonatal Abstinence Syndrome; Opiate Substitution Treatment; Opioid-Related Disorders; Pregnancy; Pregnancy Complications; Treatment Outcome	2017
Naltrexone in the treatment of opioid-dependent pregnant women: the case for a considered and measured approach to research. Addiction (Abingdon, England), 2013, Volume: 108, Issue:2 Topics: Buprenorphine; Female; Humans; Infant, Newborn; Methadone; Naltrexone; Narcotic Antagonists; Narcotics; Neonatal Abstinence Syndrome; Opiate Substitution Treatment; Opioid-Related Disorders; Pregnancy; Pregnancy Complications; Risk Assessment; Risk Factors; Treatment Outcome	2013

Article

Year

Methadone, Buprenorphine, and Naltrexone for the Treatment of Opioid Use Disorder in Pregnant Women.

Pharmacotherapy, 2017, Volume: 37, Issue:7

Topics: Analgesics, Opioid; Animals; Buprenorphine; Female; Humans; Infant, Newborn; Methadone; Naltrexone; Neonatal Abstinence Syndrome; Opiate Substitution Treatment; Opioid-Related Disorders; Pregnancy; Pregnancy Complications; Treatment Outcome

2017

Naltrexone in the treatment of opioid-dependent pregnant women: the case for a considered and measured approach to research.

Addiction (Abingdon, England), 2013, Volume: 108, Issue:2

Topics: Buprenorphine; Female; Humans; Infant, Newborn; Methadone; Naltrexone; Narcotic Antagonists; Narcotics; Neonatal Abstinence Syndrome; Opiate Substitution Treatment; Opioid-Related Disorders; Pregnancy; Pregnancy Complications; Risk Assessment; Risk Factors; Treatment Outcome

2013

Other Studies

6 other study(ies) available for naltrexone and Neonatal Abstinence Syndrome

Article	Year
A Retrospective Cohort Study of Birth Outcomes in Neonates Exposed to Naltrexone in Utero: A Comparison with Methadone-, Buprenorphine- and Non-opioid-Exposed Neonates. Drugs, 2017, Volume: 77, Issue:11 Topics: Adult; Australia; Buprenorphine; Drug Administration Routes; Female; Humans; Incidence; Infant, Newborn; Male; Methadone; Naltrexone; Neonatal Abstinence Syndrome; Opiate Substitution Treatment; Opioid-Related Disorders; Pregnancy; Pregnancy Complications; Pregnancy Outcome; Prenatal Exposure Delayed Effects; Retrospective Studies	2017
Use of naltrexone in treating opioid use disorder in pregnancy. American journal of obstetrics and gynecology, 2020, Volume: 222, Issue:1 Topics: Abortion, Spontaneous; Adult; Analgesics, Opioid; Buprenorphine; Case-Control Studies; Female; Humans; Infant, Newborn; Methadone; Naltrexone; Narcotic Antagonists; Neonatal Abstinence Syndrome; Opiate Substitution Treatment; Opioid-Related Disorders; Pregnancy; Pregnancy Complications; Prospective Studies; Stillbirth; Young Adult	2020
Dual dilemma-should naltrexone be used in the treatment of opioid-dependent pregnant women? Addiction (Abingdon, England), 2013, Volume: 108, Issue:2 Topics: Buprenorphine; Female; Humans; Infant, Newborn; Methadone; Naltrexone; Narcotic Antagonists; Narcotics; Neonatal Abstinence Syndrome; Opiate Substitution Treatment; Opioid-Related Disorders; Pregnancy; Pregnancy Complications; Risk Assessment; Treatment Outcome	2013
Ontogeny of morphine withdrawal in the rat. Behavioral neuroscience, 1995, Volume: 109, Issue:6 Topics: Age Factors; Animals; Arousal; Female; Humans; Infant, Newborn; Injections, Intraperitoneal; Male; Morphine; Morphine Dependence; Motor Activity; Naltrexone; Narcotic Antagonists; Neonatal Abstinence Syndrome; Neurologic Examination; Rats; Substance Withdrawal Syndrome	1995
Neonatal withdrawal following pre- and postnatal exposure to methadone in the rat. Pharmacology, biochemistry, and behavior, 1998, Volume: 60, Issue:1 Topics: Animals; Animals, Newborn; Behavior, Animal; Female; Humans; Infant, Newborn; Male; Methadone; Motor Activity; Naltrexone; Narcotic Antagonists; Neonatal Abstinence Syndrome; Pregnancy; Rats; Rats, Wistar; Substance Withdrawal Syndrome; Vocalization, Animal	1998
Naltrexone-precipitated morphine withdrawal in infant rat is attenuated by acute administration of NOS inhibitors but not NMDA receptor antagonists. Psychopharmacology, 2000, Volume: 150, Issue:3 Topics: 2-Amino-5-phosphonovalerate; Aging; Animals; Animals, Newborn; Dizocilpine Maleate; Enzyme Inhibitors; Excitatory Amino Acid Antagonists; Humans; Indazoles; Infant, Newborn; Male; Morphine; Naltrexone; Narcotic Antagonists; Narcotics; Neonatal Abstinence Syndrome; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Nitric Oxide Synthase Type I; Rats; Rats, Long-Evans; Receptors, N-Methyl-D-Aspartate	2000